Literature DB >> 22146322

Traumatic brain injury - long term care of patients in general practice.

Lyndal Trevena1, Ian Cameron.   

Abstract

BACKGROUND: Traumatic brain injury is a significant cause of disability worldwide. Patients with a traumatic brain injury may have a range of physical, mental, cognitive and social problems involving care from a general practitioner.
OBJECTIVE: This article provides a summary of the available evidence for managing the common mental health, somatic and cognitive/behavioural issues associated with traumatic brain injury. DISCUSSION: The long term sequelae of traumatic brain injury pose a number of challenges for patients, their families and GPs. Common somatic complaints include seizures, headache, dizziness and sleep disturbance. Common mental health problems include depression, psychosis and anxiety. Cognitive and behavioural or personality changes can be significant and persist for some time following injury. Quality of life is closely predicted by return to the workforce and long term functional status is often linked to the severity of the injury. There is limited evidence for effective treatments of these sequelae and a need for more research. However, there are a number of proven treatments and an emerging understanding of the long term sequelae of traumatic brain injury.

Entities:  

Mesh:

Year:  2011        PMID: 22146322

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  Initial experiences of family caregivers of survivors of a traumatic brain injury.

Authors:  Mandi Broodryk; Chrisma Pretorius
Journal:  Afr J Disabil       Date:  2015-08-11

2.  Improving the care of people with traumatic brain injury through the Neurotrauma Evidence Translation (NET) program: protocol for a program of research.

Authors:  Sally E Green; Marije Bosch; Joanne E McKenzie; Denise A O'Connor; Emma J Tavender; Peter Bragge; Marisa Chau; Veronica Pitt; Jeffrey V Rosenfeld; Russell L Gruen
Journal:  Implement Sci       Date:  2012-08-07       Impact factor: 7.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.